FY2026 EPS Estimates for Quantum-Si Boosted by HC Wainwright

Quantum-Si Incorporated (NASDAQ:QSI – Free Report) – Equities researchers at HC Wainwright boosted their FY2026 earnings per share estimates for Quantum-Si in a report released on Thursday, November 12th. HC Wainwright analyst S. Ramakanth now anticipates that the company will earn ($0.42) per share for the year, up from their prior forecast of ($0.47). HC Wainwright has a “Buy” rating on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.42) per share. HC Wainwright also issued estimates for Quantum-Si’s Q4 2026 earnings at ($0.11) EPS, Q1 2027 earnings at ($0.11) EPS and FY2027 earnings at ($0.41) EPS.

A number of other research analysts have also issued reports on the stock. UBS Group reiterated a “buy” rating on shares of Quantum-Si in a research note on Thursday. Weiss Ratings raised shares of Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, September 24th. Wall Street Zen raised shares of Quantum-Si from a “sell” rating to a “hold” rating in a research report on Tuesday, October 27th. Finally, Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Quantum-Si presently has a consensus rating of “Hold” and an average price target of $2.50.

Read Our Latest Research Report on Quantum-Si

Quantum-Si Trading Down 7.8%

NASDAQ QSI opened at $1.06 on Monday. The company has a fifty day simple moving average of $1.15 and a 200 day simple moving average of $0.97. The company has a market cap of $232.01 million, a P/E ratio of -2.72 and a beta of 3.26. Quantum-Si has a 1 year low of $0.69 and a 1 year high of $1.81.

Quantum-Si (NASDAQ:QSI – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.10) EPS for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02. Quantum-Si had a negative net margin of 6,729.80% and a negative return on equity of 44.72%. The company had revenue of $0.21 million for the quarter, compared to analyst estimates of $0.27 million.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. bought a new stake in shares of Quantum-Si in the third quarter valued at approximately $274,000. Jump Financial LLC acquired a new stake in shares of Quantum-Si in the third quarter worth $73,000. Empowered Funds LLC acquired a new stake in shares of Quantum-Si in the third quarter worth $210,000. Knollwood Investment Advisory LLC acquired a new stake in shares of Quantum-Si in the third quarter worth $321,000. Finally, Kovack Advisors Inc. bought a new position in Quantum-Si during the third quarter worth $64,000. 39.90% of the stock is owned by institutional investors.

Quantum-Si Company Profile

(Get Free Report)

Quantum-Si is a life sciences technology company developing tools for protein sequencing and proteomics research. Its platform uses semiconductor technology and single-molecule detection to analyze proteins, with the aim of making protein-level information more accessible to researchers. The company’s offerings include the Platinum benchtop instrument, along with consumables, reagents and software used to prepare, run and analyze samples. Quantum-Si’s products are designed for research applications in areas such as drug discovery and biological research.

Recommended Stories

Earnings History and Estimates for Quantum-Si (NASDAQ:QSI)

Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.